Since its first large-scale introduction in 1996, the commercial cultivation of genetically modified (GM) crops has steadily increased. Before any GM crops are allowed on the retail market, they must be assessed for their safety. This safety assessment is comparative and follows an internationally recognized consensus approach, focusing on the differences between a GM crop and its conventional counterpart. A number of issues are commonly addressed during this safety assessment, such as the potential allergenicity of newly introduced proteins.
- A brief overview of GM crop development
- The various safety assessments of GM crops
- GM crops and potential allergenicity
For your copy of our free whitepaper, just complete the form on this page.